Provided by Tiger Fintech (Singapore) Pte. Ltd.

Glaukos

92.99
+0.30000.32%
Post-market: 92.990.00000.00%19:10 EDT
Volume:653.29K
Turnover:61.03M
Market Cap:5.31B
PE:-40.99
High:95.00
Open:94.34
Low:92.92
Close:92.69
Loading ...

Truist Cuts Price Target on Glaukos to $140 From $185, Keeps Buy Rating

MT Newswires Live
·
11 Apr

Strength Seen in Veracyte (VCYT): Can Its 13.0% Jump Turn into More Strength?

Zacks
·
10 Apr

Press Release: Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30

Dow Jones
·
09 Apr

What Makes Glaukos Corporation (GKOS) a Compelling Stock?

Insider Monkey
·
08 Apr

3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space

Zacks
·
31 Mar

Glaukos Corporation (NYSE:GKOS) Is Expected To Breakeven In The Near Future

Simply Wall St.
·
27 Mar

Breakeven On The Horizon For Glaukos Corporation (NYSE:GKOS)

Simply Wall St.
·
24 Mar

RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution

Business Wire
·
11 Mar

Is Glaukos Corporation (GKOS) the Best Medical Technology Stock to Buy According to Analysts?

Insider Monkey
·
05 Mar

Glaukos’s Strong Market Position and Growth Prospects Justify Buy Rating

TIPRANKS
·
04 Mar

Stifel Nicolaus Reaffirms Their Buy Rating on Glaukos (GKOS)

TIPRANKS
·
03 Mar

Glaukos CEO Makes a Multi-Million Dollar Stock Sale!

TIPRANKS
·
01 Mar

GKOS Crashes Almost 25% After Q4 Earnings: How to Play the Stock?

Zacks
·
28 Feb

BRIEF-Glaukos Announces FDA Acceptance Of NDA Submission For Epioxa™

Reuters
·
24 Feb

Glaukos's Corneal Disease Drug Accepted for FDA Review

MT Newswires Live
·
24 Feb

Glaukos Corp - Pdufa Date for Epioxa Nda Set for October 20, 2025

THOMSON REUTERS
·
24 Feb

Glaukos Announces FDA Acceptance of Nda Submission for Epioxa™

THOMSON REUTERS
·
24 Feb

Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™

Business Wire
·
24 Feb

We're Not Worried About Glaukos' (NYSE:GKOS) Cash Burn

Simply Wall St.
·
23 Feb

Glaukos Corp. Reports Record Sales in Earnings Call

TIPRANKS
·
22 Feb